Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
advertisement
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
Visit clement-531119's column >>

CLEMENT-531119

Articles Posted: 0  Links Seeded: 8
Member Since: 9/2008  Last Seen: 10/11/2010

What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

Patient-led drug trials defy medical bureaucracy

Seeded on Thu Nov 27, 2008 12:02 PM EST
Read ArticleArticle Source: msnbc.com
science, msnbci, health-care, opinion, bureaucracy, health-politics
Seeded by clement-531119
advertisement

Dozens of ALS patients are testing treatments on their own without waiting on the slow pace of medical research.

  • Enjoy this article? Help vote it up the 'Vine.

Published to:

  • clement-531119's Column, All of Newsvine
  • Groups: none
  • Regions: none
  • Public Discussion (1)
clement-531119

If 87 patients did not have any improvement by their own evaluation, I fail to see how an double-blind study of 84 patients is going to show any difference.

People with diseases deemed terminal should have the choice of participating in "uncontrolled" studies as well as "controlled" ones. Controlled studies have their own problems too eg. Vioxx for a glaring example. I drew the conclusion from that debacle the the "gold standard" is not so much of a gold standard anyway. The idea of "double-blind" studies is to "objectively" assess the effectiveness of a drug or other treatment by getting rid of "bias". This is an ideal. I have not yet seen a single instance of a true "ideal" situation, definitely not regarding elimination of "bias".

Look at the "race" issue. Civil rights laws were passed with the best of intentions. The only thing that was not accounted for was the length of time it would take for the population at large to change their attitudes. The reason for this was that the "end point" was and is being defined as "complete absence of bias".

    Reply#1 - Thu Nov 27, 2008 12:02 PM EST
    Leave a Comment:
    You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
    You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
    (XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
    Newsvine Privacy Statement
    As a new user, you may notice a few temporary content restrictions. Click here for more info.
    FUN STUFF:
    • Leaderboard |
    • E-Mail Alerts |
    • Top of the Vine |
    • Newsvine Live |
    • Newsvine Archives |
    • The Greenhouse |
    COMPANY STUFF:
    • Code of Honor |
    • Company Info |
    • Contact Us |
    • Jobs |
    • User Agreement |
    • Privacy Policy |
    • About our ads
    LEGAL STUFF:
    • © 2005-2012 Newsvine, Inc. |
    • Newsvine® is a registered trademark of Newsvine, Inc. |
    • Newsvine is a property of msnbc.com